RedHill Biopharma Ltd. (RDHL) stock
RDHLNasdaqPharmaceutical Preparations
$0.38−0.01 (-1.60%)
Close on Nov 13, 2026Market cap $1.91MP/E –Yield –
RedHill Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
RedHill Biopharma's enterprise value was -$4.00M on Nov 11, 2026, against -$1.39M a year earlier. Over the last 5 years it ranged from -$6.31M to $171.39M, with a median of -$1.60M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$4.00M | – |
| 2025 | Dec 31, 2025 | -$1.60M | – |
| 2024 | Dec 31, 2024 | -$5.67M | – |
| 2023 | Dec 29, 2023 | -$4.75M | -107.3% |
| 2022 | Dec 30, 2022 | $65.05M | -48.1% |
| 2021 | Dec 31, 2021 | $125.33M | -57.8% |
| 2020 | Dec 31, 2020 | $296.83M | +126.0% |
| 2019 | Dec 31, 2019 | $131.35M | +42.1% |
| 2018 | Dec 31, 2018 | $92.44M | +644.2% |
| 2017 | Dec 29, 2017 | $12.42M | -87.0% |
| 2016 | Dec 30, 2016 | $95.34M | – |
See a number that looks wrong?